Metabolic syndrome relates to high risk in hepatocellular carcinoma: a meta-analysis.

In conclusion, metabolic syndrome might be associated with a high risk of HCC occurrence, especially in male and the Euro-US population. However, no statistical significances were found between MetS and HCC clinicopathological features including capsule, vascular invasion, and moderate-poor differentiation, and between MetS and HCC survivals. Prospectively, well-designed trials with large numbers of samples should be conducted to evaluate the links between MetS and HCC. PMID: 30695678 [PubMed - in process]
Source: Discovery Medicine - Category: Research Tags: Discov Med Source Type: research